SCHEMBL30294646

SCHEMBL30294646

COc1ccc(NC(=O)c2cc(C(F)(F)F)ccc2Nc2ccc(F)c(C#N)c2C)c(C)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SORT1 Q99523 6/20 0.42
▸ LCLAT1 Q6UWP7 1/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ HPGD P15428 2/20 0.40
▸ NTRK1 P04629 1/20 0.39
▸ NTRK2 Q16620 1/20 0.39
▸ GPR6 P46095 2/20 0.38
▸ DHODH Q02127 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.36
▸ TMPRSS4 Q9NRS4 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TAS2R14 Q9NYV8 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22853440 1.00 SORT1 (0.42) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL30294376 0.89 SORT1 (0.46) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL22852910 0.89 SORT1 (0.46) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL22853181 0.84 SORT1 (0.52) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL22853430 0.84 SORT1 (0.45) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL30294432 0.84 SORT1 (0.45) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL30294526 0.83 SORT1 (0.46) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL22853186 0.83 SORT1 (0.46) SORT1LCLAT1KDM4EHPGDNTRK1
SCHEMBL22853242 0.83 GPR6 (0.43) SORT1GPR6DHODHRXFP1TMPRSS4
SCHEMBL30294842 0.83 GPR6 (0.43) SORT1GPR6DHODHRXFP1TMPRSS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230103791-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-04-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230103791-A1 2,3-DIHYDROQUINAZOLIN COMPOUNDS AS NAV1.8 INHIBITORS SCN8A, SCN1A, SCN1B SORT1 3573/4885LCLAT1 3944/4885KDM4E 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback